sec document
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
--------------
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b) (c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
(Amendment No. 2)(1)
Emergency Medical Services Corporation
--------------------------------------------------------------------------------
(Name of Issuer)
CLASS A COMMON STOCK, PAR VALUE $0.01 PER SHARE
--------------------------------------------------------------------------------
(Title of Class of Securities)
29100P102
--------------------------------------------------------------------------------
(CUSIP Number)
December 31, 2006
--------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
--------------
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
/ / Rule 13d-1(b)
/x/ Rule 13d-1(c)
/ / Rule 13d-1(d)
--------------
(1) The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall
not be deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, SEE
the NOTES).
---------------------- ----------------------
CUSIP No. 29100P102 13D Page 2 of 17 Pages
---------------------- ----------------------
================================================================================
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
ACCIPITER LIFE SCIENCES FUND, LP
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / /
(b) / /
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
DELAWARE
--------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES
BENEFICIALLY 60,081 shares
OWNED BY -----------------------------------------------------------------
EACH 6 SHARED VOTING POWER
REPORTING
PERSON WITH 0 shares
-----------------------------------------------------------------
7 SOLE DISPOSITIVE POWER
60,081 shares
-----------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
0 shares
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
60,081 shares
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* / /
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.6%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
PN
================================================================================
*SEE INSTRUCTIONS BEFORE FILLING OUT!
---------------------- ----------------------
CUSIP No. 29100P102 13D Page 3 of 17 Pages
---------------------- ----------------------
================================================================================
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
ACCIPITER LIFE SCIENCES FUND (OFFSHORE), LTD.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / /
(b) / /
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
CAYMAN ISLANDS
--------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES
BENEFICIALLY 60,226 shares
OWNED BY -----------------------------------------------------------------
EACH 6 SHARED VOTING POWER
REPORTING
PERSON WITH 0 shares
-----------------------------------------------------------------
7 SOLE DISPOSITIVE POWER
60,226 shares
-----------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
0 shares
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
60,226 shares
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* / /
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.7%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
OO
================================================================================
*SEE INSTRUCTIONS BEFORE FILLING OUT!
---------------------- ----------------------
CUSIP No. 29100P102 13D Page 4 of 17 Pages
---------------------- ----------------------
================================================================================
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
ACCIPITER LIFE SCIENCES FUND II, LP
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / /
(b) / /
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
DELAWARE
--------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES
BENEFICIALLY 144,909 shares
OWNED BY -----------------------------------------------------------------
EACH 6 SHARED VOTING POWER
REPORTING
PERSON WITH 0 shares
-----------------------------------------------------------------
7 SOLE DISPOSITIVE POWER
144,909 shares
-----------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
0 shares
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
144,909 shares
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* / /
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
1.6%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
PN
================================================================================
*SEE INSTRUCTIONS BEFORE FILLING OUT!
---------------------- ----------------------
CUSIP No. 29100P102 13D Page 5 of 17 Pages
---------------------- ----------------------
================================================================================
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
ACCIPITER LIFE SCIENCES FUND II (OFFSHORE), LTD.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / /
(b) / /
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
CAYMAN ISLANDS
--------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES
BENEFICIALLY 264,614 shares
OWNED BY -----------------------------------------------------------------
EACH 6 SHARED VOTING POWER
REPORTING
PERSON WITH 0 shares
-----------------------------------------------------------------
7 SOLE DISPOSITIVE POWER
264,614 shares
-----------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
0 shares
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
264,614 shares
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* / /
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
2.9%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
OO
================================================================================
*SEE INSTRUCTIONS BEFORE FILLING OUT!
---------------------- ----------------------
CUSIP No. 29100P102 13D Page 6 of 17 Pages
---------------------- ----------------------
================================================================================
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
ACCIPITER LIFE SCIENCES FUND II (QP), LP
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / /
(b) / /
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
DELAWARE
--------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES
BENEFICIALLY 146,029 shares
OWNED BY -----------------------------------------------------------------
EACH 6 SHARED VOTING POWER
REPORTING
PERSON WITH 0 shares
-----------------------------------------------------------------
7 SOLE DISPOSITIVE POWER
146,029 shares
-----------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
0 shares
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
146,029 shares
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* / /
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
1.6%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
PN
================================================================================
*SEE INSTRUCTIONS BEFORE FILLING OUT!
---------------------- ----------------------
CUSIP No. 29100P102 13D Page 7 of 17 Pages
---------------------- ----------------------
================================================================================
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
CANDENS CAPITAL, LLC
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / /
(b) / /
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
DELAWARE
--------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES
BENEFICIALLY 0 shares
OWNED BY -----------------------------------------------------------------
EACH 6 SHARED VOTING POWER
REPORTING
PERSON WITH 351,019 shares
-----------------------------------------------------------------
7 SOLE DISPOSITIVE POWER
0 shares
-----------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
351,019 shares
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
351,019 shares
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* / /
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
3.8%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
OO
================================================================================
*SEE INSTRUCTIONS BEFORE FILLING OUT!
---------------------- ----------------------
CUSIP No. 29100P102 13D Page 8 of 17 Pages
---------------------- ----------------------
================================================================================
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
ACCIPITER CAPITAL MANAGEMENT, LLC
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / /
(b) / /
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
DELAWARE
--------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES
BENEFICIALLY 0 shares
OWNED BY -----------------------------------------------------------------
EACH 6 SHARED VOTING POWER
REPORTING
PERSON WITH 324,840 shares
-----------------------------------------------------------------
7 SOLE DISPOSITIVE POWER
0 shares
-----------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
324,840 shares
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
324,840 shares
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* / /
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
3.5%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
OO
================================================================================
*SEE INSTRUCTIONS BEFORE FILLING OUT!
---------------------- ----------------------
CUSIP No. 29100P102 13D Page 9 of 17 Pages
---------------------- ----------------------
================================================================================
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
GABE HOFFMAN
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / /
(b) / /
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
USA
--------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES
BENEFICIALLY 0 shares
OWNED BY -----------------------------------------------------------------
EACH 6 SHARED VOTING POWER
REPORTING
PERSON WITH 675,859 shares
-----------------------------------------------------------------
7 SOLE DISPOSITIVE POWER
0 shares
-----------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
675,859 shares
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
675,859 shares
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* / /
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
7.3%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
================================================================================
*SEE INSTRUCTIONS BEFORE FILLING OUT!
---------------------- ----------------------
CUSIP No. 29100P102 13D Page 10 of 17 Pages
---------------------- ----------------------
Item 1(a). Name of Issuer:
Emergency Medical Services Corporation
Item 1(b). Address of Issuer's Principal Executive Offices:
6200 S. Syracuse Way
Suite 200
Greenwood Village, Colorado 80111
Item 2(a). Name of Person Filing:
This statement is jointly filed by Accipiter Life Sciences Fund, LP,
a Delaware limited partnership ("ALSF"), Accipiter Life Sciences
Fund (Offshore), Ltd., a Cayman Islands company ("Offshore"),
Accipiter Life Sciences Fund II, LP, a Delaware limited partnership
("ALSF II"), Accipiter Life Sciences Fund II (Offshore), Ltd., a
Cayman Islands Company ("Offshore II"), Accipiter Life Sciences Fund
II (QP), LP, a Delaware limited partnership ("QP II"), Accipiter
Capital Management, LLC, a Delaware limited liability company
("Management"), Candens Capital, LLC, a Delaware limited liability
company ("Candens") and Gabe Hoffman (together with ALSF, ALSF II,
Offshore, Offshore II, QP II, Management and Candens, the "Reporting
Person"). Gabe Hoffman is the managing member of Candens (Gabe
Hoffman and Candens are hereinafter referred to as the "Domestic
Controlling Persons"), which in turn is the general partner of ALSF
and ALSF II and QP II, and the managing member of Management (Gabe
Hoffman and Management are hereinafter referred to as the "Foreign
Controlling Persons"), which in turn is the investment manager of
Offshore and Offshore II. Consequently, Mr. Hoffman, the Domestic
Controlling Persons and Foreign Controlling Persons may be deemed,
pursuant to Rule 13d-3 of the Securities Exchange Act of 1934, as
amended (the "Act"), to be the beneficial owners of all shares of
Class A Common Stock held by ALSF, ALSF II, Offshore, Offshore II
and QP II. The Reporting Persons are filing this joint statement, as
they may be considered a "group" under Section 13(d)(3) of the Act.
However, neither this filing nor anything contained herein shall be
deemed to be an admission by the Reporting Persons that such a group
exists.
Item 2(b). Address of Principal Business Office or, if None, Residence:
399 Park Avenue, 38th Floor
New York, New York 10022
Item 2(c). Citizenship:
ALSF, ALSF II, QP II, Candens and Management are organized under the
laws of the State of Delaware. Offshore and Offshore II are
organized under the laws of the Cayman Islands. Gabe Hoffman is a
citizen of the United States of America.
Item 2(d). Title of Class of Securities:
Class A Common Stock, par value $0.01 per share
---------------------- ----------------------
CUSIP No. 29100P102 13D Page 11 of 17 Pages
---------------------- ----------------------
Item 2(e). CUSIP Number:
29100P102
Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or
(c), Check Whether the Person Filing is a:
/X/ Not Applicable
(a) / / Broker or dealer registered under Section 15 of the Exchange
Act.
(b) / / Bank as defined in Section 3(a)(6) of the Exchange Act.
(c) / / Insurance company as defined in Section 3(a)(19) of the
Exchange Act.
(d) / / Investment company registered under Section 8 of the
Investment Company Act.
(e) / / An investment adviser in accordance with Rule
13d-1(b)(1)(ii)(E).
(f) / / An employee benefit plan or endowment fund in accordance with
Rule 13d-1(b)(1)(ii)(F).
(g) / / A parent holding company or control person in accordance with
Rule 13d-1(b)(1)(ii)(G).
(h) / / A savings association as defined in Section 3(b) of the
Federal Deposit Insurance Act.
(i) / / A church plan that is excluded from the definition of an
investment company under Section 3(c)(14) of the Investment
Company Act.
(j) / / Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
Item 4. Ownership
The percentages used herein are calculated based on 9,262,853 shares
of Class A Common Stock outstanding as of November 1, 2006 as
reported in the Issuer's quarterly report on Form 10-Q filed with
the Securities and Exchange Commission on November 7, 2006.
See Cover Pages, Items 5-11.
Item 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the
date hereof the reporting person has ceased to be the beneficial owner of more
than five percent of the class of securities, check the following [].
---------------------- ----------------------
CUSIP No. 29100P102 13D Page 12 of 17 Pages
---------------------- ----------------------
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
Not Applicable
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on by the Parent Holding
Company or Control Person.
Not Applicable
Item 8. Identification and Classification of Members of the Group.
See Exhibit A.
Item 9. Notice of Dissolution of Group.
Not Applicable
Item 10. Certifications.
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are not held for
the purpose of or with the effect of changing or influencing the control of the
issuer of the securities and were not acquired and are not held in connection
with or as a participant in any transaction having that purpose or effect.
---------------------- ----------------------
CUSIP No. 29100P102 13D Page 13 of 17 Pages
---------------------- ----------------------
SIGNATURE
---------
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true, complete and
correct.
Dated: January 18, 2007 ACCIPITER LIFE SCIENCES FUND, LP
By: Candens Capital, LLC
its general partner
By: /s/ Gabe Hoffman
-----------------------------------
Gabe Hoffman, Managing Member
ACCIPITER LIFE SCIENCES FUND II, LP
By: Candens Capital, LLC
its general partner
By: /s/ Gabe Hoffman
-----------------------------------
Gabe Hoffman, Managing Member
ACCIPITER LIFE SCIENCES FUND
(OFFSHORE), LTD.
By: Accipiter Capital Management, LLC
its investment manager
By: /s/ Gabe Hoffman
-----------------------------------
Gabe Hoffman, Managing Member
ACCIPITER LIFE SCIENCES FUND II
(OFFSHORE), LTD.
By: Accipiter Capital Management, LLC
its investment manager
By: /s/ Gabe Hoffman
-----------------------------------
Gabe Hoffman, Managing Member
---------------------- ----------------------
CUSIP No. 29100P102 13D Page 14 of 17 Pages
---------------------- ----------------------
ACCIPITER LIFE SCIENCES FUND II (QP),
LP
By: Candens Capital, LLC
its general partner
By: /s/ Gabe Hoffman
-----------------------------------
Gabe Hoffman, Managing Member
ACCIPITER CAPITAL MANAGEMENT, LLC
By: /s/ Gabe Hoffman
-----------------------------------
Gabe Hoffman, Managing Member
CANDENS CAPITAL, LLC
By: /s/ Gabe Hoffman
-----------------------------------
Gabe Hoffman, Managing Member
/s/ Gabe Hoffman
----------------------------------------
GABE HOFFMAN
---------------------- ----------------------
CUSIP No. 29100P102 13D Page 15 of 17 Pages
---------------------- ----------------------
EXHIBIT INDEX
The following document is filed herewith:
(a) Joint Filing Agreement dated as of January 18, 2007 among
Accipiter Life Sciences Fund, LP, Accipiter Life Sciences Fund
II, LP, Accipiter Life Sciences Fund (Offshore), Ltd.,
Accipiter Life Sciences Fund II (Offshore), Ltd., Accipiter
Life Sciences Fund II (QP), LP, Accipiter Capital Management,
LLC, Candens Capital, LLC and Gabe Hoffman.
---------------------- ----------------------
CUSIP No. 29100P102 13D Page 16 of 17 Pages
---------------------- ----------------------
EXHIBIT A
JOINT FILING AGREEMENT
----------------------
The undersigned hereby agree that the Statement on Schedule 13G dated
January 18, 2007 with respect to the shares of Common Stock of Emergency Medical
Services Corporation and any further amendments thereto executed by each and any
of the undersigned shall be filed on behalf of each of the undersigned pursuant
to and in accordance with the provisions of Rule 13d-1(k)(1) under the
Securities Exchange Act of 1934, as amended.
Dated: January 18, 2007 ACCIPITER LIFE SCIENCES FUND, LP
By: Candens Capital, LLC
its general partner
By: /s/ Gabe Hoffman
-----------------------------------
Gabe Hoffman, Managing Member
ACCIPITER LIFE SCIENCES FUND II, LP
By: Candens Capital, LLC
its general partner
By: /s/ Gabe Hoffman
-----------------------------------
Gabe Hoffman, Managing Member
ACCIPITER LIFE SCIENCES FUND
(OFFSHORE), LTD.
By: Accipiter Capital Management, LLC
its investment manager
By: /s/ Gabe Hoffman
-----------------------------------
Gabe Hoffman, Managing Member
ACCIPITER LIFE SCIENCES FUND II
(OFFSHORE), LTD.
By: Accipiter Capital Management, LLC
its investment manager
By: /s/ Gabe Hoffman
-----------------------------------
Gabe Hoffman, Managing Member
---------------------- ----------------------
CUSIP No. 29100P102 13D Page 17 of 17 Pages
---------------------- ----------------------
ACCIPITER LIFE SCIENCES FUND II (QP),
LP
By: Candens Capital, LLC
its general partner
By: /s/ Gabe Hoffman
-----------------------------------
Gabe Hoffman, Managing Member
ACCIPITER CAPITAL MANAGEMENT, LLC
By: /s/ Gabe Hoffman
-----------------------------------
Gabe Hoffman, Managing Member
CANDENS CAPITAL, LLC
By: /s/ Gabe Hoffman
-----------------------------------
Gabe Hoffman, Managing Member
/s/ Gabe Hoffman
----------------------------------------
GABE HOFFMAN